Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy

Ageing Res Rev. 2013 Sep;12(4):1024-41. doi: 10.1016/j.arr.2013.05.003. Epub 2013 May 17.

Abstract

The vast majority of Alzheimer's disease (AD) are late-onset forms (LOAD) likely due to the interplay of environmental influences and individual genetic susceptibility. Epigenetic mechanisms, including DNA methylation, histone modifications and non-coding RNAs, constitute dynamic intracellular processes for translating environmental stimuli into modifications in gene expression. Over the past decade it has become increasingly clear that epigenetic mechanisms play a pivotal role in aging the pathogenesis of AD. Here, we provide a review of the major mechanisms for epigenetic modification and how they are reportedly altered in aging and AD. Moreover, we also consider how aberrant epigenetic modifications may lead to AD pathogenesis, and we review the therapeutic potential of epigenetic treatments for AD.

Keywords: Aging; Alzheimer's disease; Epigenetics; Pathogenesis; Therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / genetics*
  • Alzheimer Disease / pathology
  • Alzheimer Disease / therapy*
  • Animals
  • DNA Methylation / drug effects
  • DNA Methylation / physiology*
  • Drug Delivery Systems / trends
  • Epigenesis, Genetic / drug effects
  • Epigenesis, Genetic / genetics*
  • Genetic Predisposition to Disease / genetics*
  • Genetic Therapy / trends
  • Humans